Otolith Labs is pioneering the first medical wearable for the treatment of chronic vertigo, a symptom experienced by 11.6 million Americans. Otolith’s patented non-invasive technology received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.
Utilizing our cutting-edge science, engineering, and clinical research, we developed a non-invasive Vestibular Resonance Therapy (nVRT) to deliver energy to the vestibular system. We look forward to making this technology available to treat vertigo symptoms and vestibular disorders as we secure our regulatory clearances in the U.S. and beyond.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 200 Massachusetts Ave Nw, Floor 7, Washington,district Of Columbia 20001,united States
- he****@****abs.com
- Industry
- Biotechnology
- Website
- otolithlabs.com
- Keywords
- Vertigo, Vestibular, Medical Wearable Technology, Vestibulogenic Vertigo, Chronic Vertigo, Inner Ear, Dizziness, Otolaryngology, VR Sickness.
- HQ
- Washington, District of Columbia
Otolith Labs Questions
Otolith Labs's website is otolithlabs.com
Otolith Labs's LinkedIn profile is https://www.linkedin.com/company/otolith-labs
Otolith Labs has
20 employees.
View email and phone details for 20
employees at Otolith Labs.
Otolith Labs's industry is
Biotechnology
Otolith Labs's top competitors are
Vestibular First,
Spark Biomedical Inc,
Paradromics,
Ortho-Tag,
Osteoboost Health,
Sound Scouts,
Otomagnetics, Inc,
Qcatalyst,
Caira Surgical,
Inia Biosciences.
Otolith Labs's support email address is hello@otolithlabs.com
Otolith Labs's categories are Biotechnology
Otolith Labs's founding year is 2015
